Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder that affects a significant number of women during their reproductive years, making it a topic of considerable research interest [1]. Additionally, PCOS is recognized as a leading cause of anovulatory infertility, further highlighting its clinical significance [1]. The phenomenon of ovarian morphology change was initially documented by Chereau in 1844 [2]. Subsequently, the diagnostic criteria for this condition were established by the European Society for Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM) in 2003. These criteria, known as the Rotterdam Consensus Criteria, were developed based on comprehensive research conducted over several decades. Polycystic ovary syndrome (PCOS) is a complex and diverse medical condition characterized by a wide range of clinical manifestations. These manifestations primarily consist of menstrual irregularities, such as menstrual disorder and secondary amenorrhea, as well as abnormal levels of hormones in the bloodstream. Other common clinical features associated with PCOS include excessive hair growth (hirsutism), acne, obesity, and difficulties in conceiving (infertility) [3].